Stock Taper Net Sales: $33.5 million, up 9.3% year-over-year from $30.7 million.
Gross Margin: Improved to 17%, up from 15.8% in Q2 2025.
Operating Income: $623,000, down from $742,000 in the prior year.
Net Income: $316,000 ($0.11 per diluted share), slightly up from $313,000 ($0.12 per diluted share) in Q2 2025.
Total Backlog: $93.8 million, up 3.4% from the previous quarter and 19.8% year-over-year.
Cash and Restricted Cash: Totaled $1.7 million; revolving credit facility balance at $7.6 million with $3.6 million unused availability.
Continued execution of restructuring initiatives from late 2024 and early 2025 is yielding operational and financial benefits.
Strong growth in the medical device market (36% year-over-year) and a 12.2% increase in medical imaging sales.
Aerospace and Defense sales decreased by 12.8%, primarily due to one customer reducing inventory levels.
Increased customer engagement and successful program transfers noted, particularly in aerospace, defense, and medical imaging sectors.
New Vice President of Supply Chain hired to strengthen supply chain leadership amid ongoing component constraints and price volatility.
Focus on nearshore manufacturing strategies with operations in the U.S., Mexico, and China.
Management remains optimistic about continued sales momentum in 2026, supported by a strong backlog and stabilization in supply chains.
Plans to reduce inventory investments and generate cash from working capital reductions.
Anticipation of further gross margin expansion as operational leverage improves with increased production.
Operating expenses rose to $5.1 million, up from $4.1 million year-over-year, largely due to increased incentive compensation.
Aerospace and Defense segment showed a decline in sales, raising concerns about dependency on specific customers and market fluctuations.
Uncertainty surrounding tariff reimbursements and geopolitical risks affecting supply chain dynamics.
Cash used in operating activities was $2.4 million in the first half of 2026, indicating ongoing cash flow challenges.
Operating Expenses: Majority of the increase attributed to incentive compensation and stock-based compensation.
Data Center Opportunities: Management is exploring opportunities in data centers but has not yet secured significant business in that area.
Capacity Utilization: Sufficient capacity exists to support growth without significant capital expenditures; potential for adding shifts to increase output.
Gross Margin Expansion: Management believes there are levers for further gross margin improvement through better utilization of fixed costs and favorable product mix.
Go-to-Market Strategy: The business development team is actively pursuing partnerships and direct opportunities in the data center space. Overall, Nortech Systems demonstrated solid growth in sales and backlog, with strategic initiatives aimed at enhancing operational efficiency and market positioning, despite facing challenges in specific segments and rising operating costs.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT